Literature DB >> 15619419

Comparison of differing C-reactive protein assay methods and their impact on cardiovascular risk assessment.

Jessica L Clarke1, Jeffrey L Anderson, John F Carlquist, Richard F Roberts, Benjamin D Horne, Tami L Bair, Matthew J Kolek, Chrissa P Mower, Ashle M Crane, William L Roberts, Joseph B Muhlestein.   

Abstract

A medium-sensitivity assay for C-reactive protein (CRP) was compared with a high-sensitivity, enhanced immunoturbidimetric assay in 803 angiographically studied patients. Different absolute CRP values were found by the assays, but there was a high correlation by quartile rank and similar predictive values for death and myocardial infarction. This suggests that the conclusions of previous studies performed using the medium-sensitivity assay are still valid but that cross-study comparisons should use percentile rank.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15619419     DOI： 10.1016/j.amjcard.2004.08.087

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  9 in total

1.  Generating genetic risk scores from intermediate phenotypes for use in association studies of clinically significant endpoints.

Authors:  B D Horne; J L Anderson; J F Carlquist; J B Muhlestein; D G Renlund; T L Bair; R R Pearson; N J Camp
Journal:  Ann Hum Genet       Date:  2005-03       Impact factor: 1.670

2.  Soluble CD40 ligand as a predictor of coronary artery disease and long-term clinical outcomes in stable patients undergoing coronary angiography.

Authors:  Matthew T Rondina; Jason M Lappé; John F Carlquist; Joseph B Muhlestein; Matthew J Kolek; Benjamin D Horne; Robert R Pearson; Jeffrey L Anderson
Journal:  Cardiology       Date:  2007-08-27       Impact factor: 1.869

3.  Serum, plasma, and dried blood spot high-sensitivity C-reactive protein enzyme immunoassay for population research.

Authors:  Eleanor Brindle; Masako Fujita; Jane Shofer; Kathleen A O'Connor
Journal:  J Immunol Methods       Date:  2010-09-17       Impact factor: 2.303

4.  The effects of endothelial lipase gene (LIPG) variants on inflammation marker levels and atherosclerosis development.

Authors:  Altay Burak Dalan; Bahar Toptaş; Zehra Buğra; Nihat Polat; Hülya Yılmaz-Aydoğan; Arif Çimen; Turgay Isbir
Journal:  Mol Biol Rep       Date:  2013-05-15       Impact factor: 2.316

5.  C-reactive protein, inflammatory conditions, and cardiovascular disease risk.

Authors:  Ravi Dhingra; Philimon Gona; Byung-Ho Nam; Ralph B D'Agostino; Peter W F Wilson; Emelia J Benjamin; Christopher J O'Donnell
Journal:  Am J Med       Date:  2007-12       Impact factor: 4.965

6.  Inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patients.

Authors:  Srinivasan Beddhu; Alfred K Cheung; Brett Larive; Tom Greene; George A Kaysen; Andrew S Levey; Michael Rocco; Mark Sarnak; Robert Toto; Garabed Eknoyan
Journal:  J Ren Nutr       Date:  2007-11       Impact factor: 3.655

7.  Oriented Antibody Covalent Immobilization for Label-Free Impedimetric Detection of C-Reactive Protein via Direct and Sandwich Immunoassays.

Authors:  Abiola Adesina; Philani Mashazi
Journal:  Front Chem       Date:  2021-06-02       Impact factor: 5.221

8.  The effects of resistance and endurance training on risk factors of vascular inflammation and atherogenesis in non-athlete men.

Authors:  Mehdi Mogharnasi; Kazem Cheragh-Birjandi; Sadegh Cheragh-Birjandi; Hossein TaheriChadorneshin
Journal:  Interv Med Appl Sci       Date:  2017-12

9.  Long period grating in double cladding fiber coated with graphene oxide as high-performance optical platform for biosensing.

Authors:  Flavio Esposito; Lucia Sansone; Anubhav Srivastava; Francesco Baldini; Stefania Campopiano; Francesco Chiavaioli; Michele Giordano; Ambra Giannetti; Agostino Iadicicco
Journal:  Biosens Bioelectron       Date:  2020-10-22       Impact factor: 10.618
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.